Detalhe da pesquisa
1.
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
Cancer Immunol Immunother
; 73(1): 4, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175294
2.
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis.
Oncology
; 101(5): 303-312, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689929
3.
Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib.
BMC Cancer
; 23(1): 834, 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674153
4.
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.
Eur J Clin Pharmacol
; 79(4): 503-511, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773042
5.
Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study.
Oncologist
; 27(11): 982-990, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36067268
6.
Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study.
Invest New Drugs
; 40(3): 634-642, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024985
7.
Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.
Invest New Drugs
; 40(2): 361-369, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088212
8.
Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer.
BMC Cancer
; 22(1): 775, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840951
9.
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes.
BMC Cancer
; 22(1): 1148, 2022 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348317
10.
Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.
Invest New Drugs
; 39(3): 853-859, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405089
11.
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion.
Invest New Drugs
; 39(4): 1106-1112, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33544282
12.
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.
BMC Cancer
; 21(1): 346, 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794809
13.
Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.
Invest New Drugs
; 38(1): 211-218, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784866
14.
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab.
BMC Cancer
; 20(1): 93, 2020 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32013910
15.
Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).
Invest New Drugs
; 37(6): 1266-1273, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31392549
16.
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
Int J Clin Oncol
; 24(7): 731-770, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31049758
17.
Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations.
Invest New Drugs
; 36(4): 608-614, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101518
18.
A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 36(4): 667-673, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572782
19.
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
BMC Cancer
; 18(1): 6, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29291705
20.
Severe acute interstitial lung disease after nivolumab in three non-small cell lung cancer patients with imaging findings of airway obstruction adjacent to lung tumors.
J Infect Chemother
; 23(12): 826-829, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28818548